Bet on health with ‘Obesity ETF’ and other index funds
Janus Capital Group this week filed a preliminary prospectus with the SEC for four new, health-related ETFs, covering obesity, health and fitness, long-term care and organic products.
Janus Capital Group this week filed a preliminary prospectus with the SEC for four new, health-related ETFs, covering obesity, health and fitness, long-term care and organic products.
CRISPR gene editing technology is one of the most intriguing growth fields in biotech, says Deerfield Management president Jim Flynn. The venture firm just launched a new $550 million fund, and it'll focus on seeding startups and funding new companies - and is very interested in this space.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.